3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
5
Phase 4
2
Phase 3
2
Phase NA
1
Phase 1/2
1
Phase 1
1
Status
Completed
5
Unknown
2
Recruiting
2
Terminated
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
1
Conditions
Vomiting
1
Prostatic Neoplasms
1
Nausea
1
Interventions
Metformin
16
Cyclophosphamide
15
Drug Therapy
14
Dexamethasone
14
Cisplatin
14
Cytarabine
11
Gemcitabine
10
Radiotherapy
9
Carboplatin
9
Vincristine
8
Paclitaxel
8
Oxaliplatin
8
Idarubicin
8
Etoposide
8
Docetaxel
8
ulipristal acetate
7
icotinib
7
Sodium Chloride
7
Methotrexate
7
Fluorouracil
7
Dexmedetomidine
7
entecavir
6
Thalidomide
6
Surgical Procedures, Operative
6
Sorafenib
6
Pemetrexed
6
Leuprolide
6
Granulocyte Colony-Stimulating Factor
6
Epirubicin
6
Doxorubicin
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Unknown
×
Calcium Dobesilate
×
Clear all
NCT03432949
2024-01-24
TRANCE
University Health Network, Toronto
Phase 4
Unknown
24 enrolled
NCT01913990
2017-01-30
ER11-02
Ottawa Hospital Research Institute
Phase 4
Unknown
323 enrolled